Sign in
4

Changes in Ownership

AYTU BIOPHARMA, INC Filed Acc 0001437749-25-010224

Chief Commercial Officer acquired 209 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

PYSZCZYMUKA GREG · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-31 Exercise or conversion : show line 1 in the form +209 23,602 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-31 Exercise or conversion : show line 2 in the form Restricted Stock Units −209 0 D
Loading xslF345X05/rdgdoc.xml…